Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
01/2004
01/07/2004EP1377975A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
01/07/2004EP1377974A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound
01/07/2004EP1377973A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light
01/07/2004EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
01/07/2004EP1377970A1 Optical data carrier containing a cyclizable compound in the information layer
01/07/2004EP1377968A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer
01/07/2004EP0958285B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES
01/07/2004CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
01/02/2004EP1374234A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound
01/02/2004EP1374233A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g
01/02/2004EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds
01/02/2004EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof
01/02/2004EP1373214A1 Rylene derivatives and their use as dyes
01/02/2004EP1373213A1 A process for the synthesis of an annulated pyridine base
01/01/2004US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040001970 Organic electroluminescent materials and devices made from such materials
12/2003
12/31/2003WO2004000816A1 Androgen receptor agonist
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030235712 Metal coordination compound and electroluminescence device
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/24/2003CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/18/2003US20030232990 For therapy of arteriosclerosis and dyslipidaemias
12/17/2003EP1370612A2 Thermochromic rylene dyes
12/17/2003CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer
12/17/2003CN1462358A Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer
12/17/2003CN1131229C Salt of naphthyridine carboxylic acid derivative
12/17/2003CN1131216C Condensed 1,2-indene dihydride and its salt for medicine its preparation method and application
12/11/2003US20030229099 Novel farnesyl protein transferase inhibitors as antitumor agents
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/10/2003EP1369417A1 Acridine derivatives
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/10/2003CN1130199C Improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099336A1 Formulation for parenteral administration of sodium channel blockers
12/04/2003WO2003099280A1 Novel formulation for the parenteral application of crobenetine
12/04/2003WO2003057145A3 SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
12/04/2003US20030225110 Tetrahydroquinoline derivatives as antithrombotic agents
12/04/2003CA2487153A1 New formulation for the parenteral application of crobenetine
12/04/2003CA2487150A1 New formulation for parental application of sodium channel blocker
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
11/2003
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097607A1 Tetrahydroisoquinoline derivatives
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220397 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003CA2486764A1 Tetrahydroisoquinoline derivatives
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363620A2 Use of fredericamycin and its derivatives in the treatment of pin1-associated states
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003CA2261032C Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003087059A3 (e)-oxime ether derivative of 5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
11/20/2003WO2003015715A3 Tetrahydroquinoline derivatives as antithrombotic agents
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
11/19/2003EP1080076B1 Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
11/19/2003EP0796849B1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003028727A9 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors
11/13/2003US20030212089 Arylindenopyridines and related therapeutic and prophylactic methods
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/11/2003US6645975 Process for the preparation of dinaposoline
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003US6645428 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
11/06/2003WO2003091345A1 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides
11/06/2003WO2003091220A1 Muscarinic antagonists
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003CA2484217A1 Muscarinic antagonists
11/05/2003EP1359146A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
11/04/2003US6642248 Antitumor, anticancer agent
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6641889 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer
10/2003
10/30/2003WO2003089415A1 Amonafide salts
10/30/2003WO2003088963A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003WO2003043582A3 Modulators of rho c activity
10/30/2003US20030203932 Amonafide salts
10/30/2003US20030203923 Method of inhibiting neurotrophin-receptor binding
10/30/2003CA2488929A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003CA2482445A1 Amonafide salts
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355650A1 New combination of active ingredients containing alfuzosine and apomorphine
10/29/2003EP0977739B1 Synthesis of intermediates useful in preparing tricyclic compounds
10/28/2003US6639075 Lactam-aldehyde compound and process of preparing same
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638941 Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domains
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087059A2 (e)-oxime ether derivative of 5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 110